BioSpace News Archive

Policy

Teleflex Announces FDA Clearance for Expanded Indication of the UroLift® System for Treatment of Larger Prostates, Up to 100cc

Minimally Invasive Procedure Now Available to Hundreds of Thousands More Men with Enlarged Prostate, Providing Safe and Effective Symptom Relief

January 7, 2020
·
5 min read
Business

IFM Therapeutics Appoints Michael Cooke, Ph.D., as Chief Scientific Officer

IFM Therapeutics, a privately-held biopharmaceutical company focused on developing therapies that modulate novel targets in the innate immune system, announced the appointment of Michael Cooke, Ph.D., as Chief Scientific Officer.

January 7, 2020
·
2 min read
Job Trends

Co-Diagnostics, Inc. Breakthrough CoPrimer™ Technology to be Featured at PAG XXVIII

Co-Diagnostics, Inc. announced that the Company’s groundbreaking Co-Diagnostics CoPrimer™ technology will be featured at the International Plant & Animal Genome XXVIII conference, held on January 11-15 in San Diego, CA.

January 7, 2020
·
3 min read
Drug Development

CureVac Announces Positive Results in Low Dose – 1 µg – Rabies Vaccine Clinical Phase 1 Study

CureVac AG announced positive data from an interim analysis of safety and immunogenicity in its Phase 1 study evaluating CV7202, a novel prophylactic mRNA-based rabies vaccine.

January 7, 2020
·
3 min read
Bio NC

G1 Therapeutics to Present at 38th Annual J.P. Morgan Healthcare Conference

G1 Therapeutics, Inc., a clinical-stage oncology company, announced that Chief Executive Officer Mark Velleca, M.D., Ph.D. will present a company overview at the 38th Annual J.P. Morgan Healthcare Conference.

January 7, 2020
·
1 min read
Genetown

TCR² Therapeutics to Present at the 38th Annual J.P. Morgan Healthcare Conference

TCR2 Therapeutics Inc. announced that Garry Menzel, Ph.D., President and Chief Executive Officer of TCR2 Therapeutics, will present a company overview at the 38th Annual J.P. Morgan Healthcare Conference on January 16, 2020 at 11:00am P.T. in San Francisco, CA.

January 7, 2020
·
1 min read
Business

MiNA Therapeutics Announces Research Collaboration with AstraZeneca in Metabolic Diseases

MiNA Therapeutics, the pioneer in RNA activation therapeutics, announced the initiation of a research collaboration with AstraZeneca to evaluate small activating RNA molecules in metabolic diseases.

January 7, 2020
·
2 min read
Pharm Country

AI Therapeutics Announces Significant Progress on LAM-001 and LAM-004 Programs

AI Therapeutics is a clinical-stage biopharmaceutical company that has created an artificial intelligence-driven drug development platform for matching drugs to new indications.

January 7, 2020
·
3 min read
Business

Alzheon Announces Appointment of Peter N. Laivins as Head of Commercial Strategy and Planning

Industry veteran brings broad commercial expertise in neuroscience drug development and commercialization as Alzheon advances ALZ-801 into Phase 3 as potentially the first oral disease-modifying treatment for Alzheimer’s disease

January 7, 2020
·
5 min read
Biotech Bay

TherapeuticsMD, An Innovative Women’s Healthcare Company, And PlushCare, A Virtual Health Platform, Announce Enhanced Access To Women’s Health Products

TherapeuticsMD, Inc. and PlushCare announced that TherapeuticsMD’s women’s health products can be prescribed to patients via the PlushCare platform.

January 7, 2020
·
5 min read